Clinical Trial

Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity

Study acronym: MMF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 31, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of the project is to analyse gene expression in individual types of ectopic endometrium (ovarian endometriosis, peritoneal endometriosis, deep infiltrating endometriosis) and compare it with gene expression in eutopic endometrium. The analysis focuses on the identification of genes with significantly increased expression in each type of ectopic endometrium and comparison of their expression with the degree of disease, ovarian reserve and clinical manifestations of the disease (pain, infertility).
Trial Details
NCT Number NCT06020482
Lead Sponsor General University Hospital, Prague
Conditions Molecular Markers of Fibrosis of Single Types of Endometriosis and Their Use in Predicting Disease Severity
Enrollment 120 participants
Start Date 2023-04-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-08-31